Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie — Clinical Trial Site

78 Registered trials

29 Currently recruiting

Organisation

Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie

Location

Lublin, Poland

Identifier

ORG-100043010

Address

Ul. Stanislawa Staszica 16, 20-081, Poland

Departments

Department of Hematooncology and Bone Marrow Transplantation
Hematology
Hematology and Bone Marrow Transplantation
I Klinika Ginekologii Onkologicznej i Ginekologii
II Klinika Anestezjologii i Intensywnej Terapii
II Klinika Anestezjologii i Intensywnej Terapii SPSK 1
Katedra i Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej
Katedra i Klinika Hematologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacj
Klinika Chirurgii Onkologicznej
Klinika Chirurgii Siatkówki i Ciała Szklistego
Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej
Klinika Dermatologii, Wenerologii I Dermatologii Dzieciecej Gabinet Badań Klinicznych
Klinika Hematologii i Transplantacji Szpiku
Klinika Hematoonkologii
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku Oddział Hematoonkologii i Transplantacji Szpiku i Ch
Klinika Hematoonkologii i Transplantacji Szpiku UM
Klinika Hematoonkologii i Transplantacji Szpiku UM w Lublinie
Klinika Hematoonkologii, Transplantacji Szpiku i Chemioterapii
N/A
NA
Oddzial Hematoonkologii, Transplantacji Szpiku i Chemioterapii
Oddzial Onkologii i Chemioterapii Kliniki Chrurgii Onkologicznej
Oddzial Onkologii Klinicznej
Oddzial Onkologii Klinicznej i Chemioterapii
Oddział Chirurgii Siatkówki i Ciała Szklistego
Oddział Dermatologii i Wenerologii
Oddział Hematologii, Transplantacji Szpiku i Chemioterapii
Oddział Hematoonkologii Transplantacji Szpiku i Chemioterapii
Oddział Hematoonkologii, Transplantacji Szpiku i Chemioterapii
Oncology
Ophthalmology Department
Szpital Kliniczny nr 1 w Lublinie
Zakład Diagnostyki Obrazowej

Clinical trials at this site (78)

Search interface

The assessment of bevacizumab dose equivalence in ovarian cancer Pending

2023-509659-15-00 Patients with ovarian cancer, fallopian tube cancer, pe 6
A study aimed at Optimise and Personalise Immunological Therapy of relapsed chronic lymphocytic leukaemia patients (OPTIC) Pending

2024-513917-11-01 Adult patients with chronic lymphocytic leukemia/small 9
Evaluation of the efficacy and safety of Magnetic Resonance Angiography (MRA) using gadopiclenol compared to gadoterate meglumine in the ass… Pending

2024-518835-13-00 Suspected Vascular Disease of supra-aortic (carotid/ver 5
A Phase 2 Study of JNJ-79635322 in Participants with RRMM Recruiting

2025-521976-80-00 Relapsed or Refractory Multiple Myeloma (RRMM) 4 2026-05-28
Studies testing Ziftomenib together with standard treatments in adults with newly diagnosed acute myeloid leukemia (AML) that has specific g… Recruiting

2025-521314-25-00 NPM1-m and KMT2A-r Acute Myeloid Leukemia 5 2026-03-19
RVU120 Rollover Study Recruiting

2025-521673-14-00 Relapsed / Refractory Metastatic or Advanced Solid Tumo 4 2025-12-03
Phase 3 Study of T-DXd and Rilvegostomig versus Standard of Care in Advanced HER2-expressing Biliary Tract Cancer Recruiting

2023-508057-19-00 Advanced HER2-expressing Biliary Tract Cancer 5 2025-09-23
A study to assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia Recruiting

2024-515451-38-00 Primary Immune thrombocytopenia (ITP) 5 2025-02-27
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis Recruiting

2022-501427-24-00 Nonadvanced Systemic Mastocytosis 4 2023-04-25
A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Parsacl… Recruiting

2022-501687-18-00 Advanced malignancies and IAI diseases 4 2020-10-28
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Arm A (AML): Newly diagnosed de novo Acute myeloid leuk 6 2025-12-19
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting

2025-522860-34-00 Chronic lymphocytic leukemia (CLL) 5 2025-12-16
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antim… Recruiting

2024-517140-65-00 Multiple Myeloma (MM). 9 2025-10-23
Phase IIIb Study of 36-Week Refill Exchanges of Port Delivery System with Ranibizumab in nAMD Recruiting

2024-516924-32-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2025-10-17
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell… Recruiting

2024-516234-35-00 Relapsed or Refractory B-Cell Malignancies 9 2025-10-15
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A Recruiting

2025-520490-38-00 Haemophilia A with or without inhibitors. Proposed indi 3 2025-10-13
A Study of ASTX030 (Cedazuridine in Combination with Azacitidine) in MDS, CMML, or AML Recruiting

2024-515098-93-00 Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic 5 2025-07-22
A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) i… Recruiting

2024-516633-12-00 Locally advanced/ metastatic gastroesophageal junction 5 2025-06-30
The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOncaRdiac surgery. Recruiting

2023-508255-39-00 hypotension in non-cardiac surgery 5 2025-06-16
Phase 3 study of belantamab mafodotin, lenalidomide, and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in pa… Recruiting

2024-516030-35-00 Multiple myeloma 5 2025-04-30
A clinical study of zilovertamab vedotin in people with large B-cell lymphoma (MK-2140-010) Recruiting

2024-515566-13-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2025-03-19
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia Recruiting

2023-505232-36-00 Essential thrombocythemia 5 2024-11-15
Study of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Recruiting

2024-513098-31-00 Relapsed or Refractory Aggressive B-cell Non-Hodgkin Ly 4 2024-11-14
Ruxolitinib rollover study Recruiting

2023-507225-42-00 Myelofibrosis 4 2024-11-05